Chapter 1. Anti-viral Therapeutics Market - Scope & Methodology
1.1    Market Segmentation
1.2    Assumption
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Anti-viral Therapeutics Market - Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
         2.3.2    Impact on Supply – Demand
Chapter 3. Anti-viral Therapeutics Market - Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Anti-viral Therapeutics Market - Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
         4.4.1     Bargaining Power of Suppliers
         4.4.2     Bargaining Powers of Customers
         4.4.3    Threat of New Entrants
         4.4.4     Rivalry among Existing Players
         4.4.5    Threat of Substitutes
Chapter 5. Anti-viral Therapeutics Market - Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Anti-viral Therapeutics Market - By Drug

6.1    Hepatitis Antiviral Drug
6.2    Herpes Antiviral Drug
6.3    HIV Antiviral Drug
6.4    Influenza Antiviral Drug

Chapter 7. Anti-viral Therapeutics Market - By Therapy

7.1    DNA Polymerase Inhibitors
7.2    Neuraminidase Inhibitors
7.3    Protease Inhibitors
7.4    Reverse Transcriptase Inhibitors
 Chapter 8. ANTI-VIRAL THERAPEUTICS MARKET - By Distribution

8.1    Hospital Pharmacy
8.2    Independent Pharmacy & Drug Store
8.3    Online Pharmacy
Chapter 9. Anti-viral Therapeutics Market – By Region
9.1    North America
9.2    Europe
9.3    Asia-Pacific
9.4    Latin America
9.5    The Middle East
9.6    Africa
Chapter 10. Anti-viral Therapeutics Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1    Company 1
10.2    Company 2
10.3    Company 3
10.4    Company 4
10.5    Company 5
10.6    Company 6
10.7    Company 7
10.8    Company 8
10.9    Company 9
10.10    Company 10